Cargando…

The international X-linked hypophosphataemia (XLH) registry (NCT03193476): rationale for and description of an international, observational study

BACKGROUND: X-linked hypophosphataemia (XLH) is a rare, hereditary, progressive and lifelong phosphate wasting disorder characterised by pathological elevations in fibroblast growth factor (FGF) 23 concentration and activity; XLH has an incidence of approximately 1 in 20–25,000 individuals. Excess F...

Descripción completa

Detalles Bibliográficos
Autores principales:	Padidela, Raja, Nilsson, Ola, Makitie, Outi, Beck-Nielsen, Signe, Ariceta, Gema, Schnabel, Dirk, Brandi, Maria Luisa, Boot, Annemieke, Levtchenko, Elena, Smyth, Michael, Jandhyala, Ravi, Mughal, Zulf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329472/ https://www.ncbi.nlm.nih.gov/pubmed/32605590 http://dx.doi.org/10.1186/s13023-020-01434-4

Ejemplares similares

The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical data
por: Ariceta, Gema, et al.
Publicado: (2023)

Post-authorisation safety study of burosumab use in paediatric, adolescent and adult patients with X-linked hypophosphataemia: rationale and description
por: Brandi, Maria Luisa, et al.
Publicado: (2022)

FGF23 and its role in X-linked hypophosphatemia-related morbidity
por: Beck-Nielsen, Signe Sparre, et al.
Publicado: (2019)

XLH Matters 2022: Insights and recommendations to improve outcomes for people living with X-linked hypophosphataemia (XLH)
por: Seefried, Lothar, et al.
Publicado: (2023)

Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment
por: Kamenicky, Peter, et al.
Publicado: (2023)

SUN-524 Burosumab Initiation In A UK XLH Cohort: Real-World Use Resonates With Research Evidence
por: Dharmaraj, Poonam, et al.
Publicado: (2019)

Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia
por: Haffner, Dieter, et al.
Publicado: (2019)

Validation of a next-generation sequencing (NGS) panel to improve the diagnosis of X-linked hypophosphataemia (XLH) and other genetic disorders of renal phosphate wasting
por: Thiele, Susanne, et al.
Publicado: (2020)

Exploring the Burden of X-Linked Hypophosphataemia: An Opportunistic Qualitative Study of Patient Statements Generated During a Technology Appraisal
por: Ferizović, Nermina, et al.
Publicado: (2019)

Clinical guidelines for burosumab in the treatment of XLH in children and adolescents: British paediatric and adolescent bone group recommendations
por: Padidela, Raja, et al.
Publicado: (2020)

Metabolic bone disease of prematurity—National survey of current neonatal and paediatric endocrine approaches
por: Chinoy, Amish, et al.
Publicado: (2020)

Burosumab for X-linked hypophosphataemia
Publicado: (2021)

Oral health‐related quality of life in X‐linked hypophosphataemia and osteogenesis imperfecta
por: Gjørup, Hans, et al.
Publicado: (2020)

Burden of disease associated with X-linked hypophosphataemia in adults: a systematic literature review
por: Seefried, L., et al.
Publicado: (2020)

Severe hypophosphataemia after intravenous iron administration
por: Anand, Gurpreet, et al.
Publicado: (2017)

Isolated hypophosphataemia as an early marker of primary hyperparathyroidism
por: Alexander, John, et al.
Publicado: (2021)

X-linked Hypophosphatemia (XLH) Mimicking Rheumatic Disease
por: Takase, Ryosuke, et al.
Publicado: (2020)

The ankle in XLH: Reduced motion, power and quality of life
por: Akta, Celine, et al.
Publicado: (2023)

OR13-2 Burosumab Resulted in Greater Improvement in Rickets Than Conventional Therapy in Children with X-Linked Hypophosphatemia (XLH)
por: Imel, Erik, et al.
Publicado: (2019)

Healthcare resource utilization in the management of hypophosphatasia in three patients displaying a spectrum of manifestations
por: Daniel, Anjali B., et al.
Publicado: (2018)

Life-threatening hypophosphataemia in a cirrhotic patient with jaundice
por: Moutzouri, Elisavet, et al.
Publicado: (2011)

Hypophosphataemia among Severely-malnourished Children: Case Series
por: Yoshimatsu, Shoji, et al.
Publicado: (2012)

Left Ventricular Hypertrophy in Patients with X-Linked Hypophosphataemia
por: Castellano-Martinez, Ana, et al.
Publicado: (2022)

Phenotypes of a family with XLH with a novel PHEX mutation
por: Yamamoto, Akiko, et al.
Publicado: (2020)

SUN-363 Hypophosphatemia Gene Panel Sponsored Program: A High Yield Of Molecular Diagnoses from Clinically Confirmed XLH and Suspected XLH/ Genetic Hypophosphatemia
por: Miller, Nicole, et al.
Publicado: (2020)

Randomized Control Trial Assessing Impact of Increased Sunlight Exposure versus Vitamin D Supplementation on Lipid Profile in Indian Vitamin D Deficient Men
por: Patwardhan, Vivek G., et al.
Publicado: (2017)

To study impact of treatment with Rosuvastatin versus Atorvastatin on 25 hydroxy Vitamin D concentrations among adult Indian men- a randomized control trial
por: Patwardhan, Vivek G., et al.
Publicado: (2020)

Incidence, severity and timing of hypophosphataemia in Glasgow Royal Infirmary ICU
por: Gilhooly, CJ, et al.
Publicado: (2009)

Acute onset quadriparesis following oesophagectomy due to isolated hypophosphataemia
por: Naik, Vibhavari M, et al.
Publicado: (2019)

Clinical factors associated with severe hypophosphataemia after kidney transplant
por: Ralston, Maximilian R., et al.
Publicado: (2021)

Hepatic osteodystrophy with hypophosphataemia and elevated fibroblast growth factor‐23
por: Ng, Nicholas Beng Hui, et al.
Publicado: (2022)

Young XLH Patients-Reported Experience with a Supportive Care Program
por: Rothenbuhler, Anya, et al.
Publicado: (2023)

Cost-Effectiveness of Vitamin D Supplementation in Pregnant Woman and Young Children in Preventing Rickets: A Modeling Study
por: Floreskul, Vilius, et al.
Publicado: (2020)

Occurrence of infections in schoolchildren subsequent to supplementation with vitamin D-calcium or zinc: a randomized, double-blind, placebo-controlled trial
por: Mandlik, Rubina, et al.
Publicado: (2020)

Vitamin D status and determinants in Indian children and adolescents: a multicentre study
por: Khadilkar, Anuradha, et al.
Publicado: (2022)

The internal thoracic artery skeletonization study: A paired, within-patient comparison [NCT00265499]
por: Boodhwani, Munir, et al.
Publicado: (2006)

Symptomatic hypophosphataemia after intravenous iron therapy: an underrated adverse reaction
por: Ifie, Eseoghene, et al.
Publicado: (2019)

New Developments in the Treatment of X-Linked Hypophosphataemia: Implications for Clinical Management
por: Saraff, Vrinda, et al.
Publicado: (2020)

SUN-523 XLH Outcome Data from One Centre Experience with Burosumab
por: Cheung, Moira, et al.
Publicado: (2019)

BALB.NCT-Cpox(nct) is a unique mouse model of hereditary coproporphyria
por: Kang, Xiaojing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0t6gl056io95qmbsig5l92rjp6